Evidence map›Paper›PMID 42395722›Full record

ArticleRSC advances2026

Revealing the selectivity source of di-2-ethylhexyl-phosphoric acid for trivalent Gd, Tb, and Dy separation.

Shengjie Yu, Youshi Lan, Wanle Liu, Guoshu Mao, Kun Huang, Yuanzhen Yue, Zhijun Song, Xuejie Sun, Xian Zhang, Shengdong Zhang and 1 more

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shengjie YuDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.
Youshi LanDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.
Wanle LiuDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.
Guoshu MaoDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.ORCID https://orcid.org/0009-0005-7805-3836
Kun HuangDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.
Yuanzhen YueDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.
Zhijun SongDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.
Xuejie SunDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.
Xian ZhangDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.
Shengdong ZhangDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.
Youqian DingDepartment of Radiochemistry, China Institute of Atomic Energy Beijing 102413 China maoguoshu@cnncmail.cn huangkun@cnncmail.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outstanding performance of the radioactive nuclide

Identifiers

PMID42395722
PMCPMC13326659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.